State warns blood banks over unethical profit through bulk transfers

State Blood Transfusion Council issues warning to blood banks against collecting excess blood and transferring it in bulk to other states for profit

Pune:  The State Blood Transfusion Council (SBTC) has issued a strict warning to blood banks against collecting excess blood and transferring it in bulk to other states for profit, officials said on Saturday.

The SBTC recently directed all blood centre heads across Maharashtra to adhere to guidelines, following complaints that some centres were deliberately collecting far more blood than needed. Allegations indicate that surplus components, especially packed red blood cells (PRBCs), were being transferred out of state or supplied to plasma fractionation companies for commercial gain, violating norms.

Dr Purushottam Puri, Assistant Director, SBTC, said, “Blood centres found violating SBTC guidelines, engaging in bulk transfers or profit-oriented practices will face strict action. Recommendations will be made to the Food and Drug Administration for cancellation of licences of such centres.”

The warning comes ahead of multiple blood donation camps planned for occasions such as Shiv Jayanti and Mahashivratri, organised by religious and social groups. Officials noted that while these camps are vital for ensuring an uninterrupted supply for patients, some centres have been collecting excessive blood and transferring it outside the state or selling it to plasma fractionators, leading to profiteering.

Dr Nisha Teli, Head of Pune District Blood Bank, said, “Following the orders, we have instructed all private blood centres to collect only the required quantity. Such practices defeat the core purpose of voluntary donation, which is to meet local patient needs. Centres with excess stock should share it with nearby government blood banks.”

Maharashtra has 373 blood banks registered with SBTC, including 57 public and private centres in Pune district.

Related Posts

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

Mumbai: A promoter entity of Ajanta Pharma Ltd. on Tuesday offloaded a nearly 3% stake in the company through open market transactions, even as domestic institutional investors stepped in to absorb a large…

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

Pune: In a major crackdown against illegal pharmaceutical activities that compromise public health, the Food and Drug Administration (FDA) has seized a stock of medicines worth above Rs24.81 lakh from…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

Pvt nursing home sealed in Chatra after woman, unborn baby die

Pvt nursing home sealed in Chatra after woman, unborn baby die

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy